Concepedia

Hongling Yang

HY

Statistics

Publications

4

Citations

71

H-Index

4

Active since

2022

Affiliations

State Key Laboratory of Biotherapy(Current)

Sichuan University

Chengdu Normal University

Southwest Jiaotong University

Hongling Yang is an author at State Key Laboratory of Biotherapy specializing in oncology, medicine, and molecular biology.

Publications per year

2022–2025

4

Publications

4

Discovery of a Novel Covalent EZH2 Inhibitor Based on Tazemetostat Scaffold for the Treatment of Ovarian Cancer

Qiangsheng Zhang, Xinyi Chen, Jiaying Cao et al. · Journal of Medicinal Chemistry · 2023 · 24 citations · Full text

, , +17

Overlooked Significance of Reactive Chlorines in the Reacted Loss of VOCs and the Formation of O<sub>3</sub> and SOA

Wei Ma, Zemin Feng, Xin Chen et al. · Environmental Science & Technology · 2025 · 17 citations

, , +17

Focus on the classical and non-classical functions of EZH2: Guide the development of inhibitors and degraders

Qiangsheng Zhang, Hongling Yang, Qiang Feng et al. · Pharmacological Research · 2022 · 16 citations

, , +3

Design, synthesis and antitumor activity of a novel FGFR2-selective degrader to overcome resistance of the FGFR2V564F gatekeeper mutation based on a pan-FGFR inhibitor

Zuli Hu, Qiangsheng Zhang, Zulong Li et al. · European Journal of Medicinal Chemistry · 2024 · 14 citations · Full text

, , +10

1–4 of 4